Immunological biomarkers in severe asthma.

Abstract excerpt

Severe asthma is heterogeneous in its clinical presentation, underlying pathophysiology, course and response to therapy. Clinical and physiological assessment of severe asthma is often inadequate in predicting underlying disease mechanisms and or response to medications. With the emergence of novel targeted therapies in severe asthma, the need for reproducible, easily measured biomarkers became obvious but only...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asthma
• Share to Breath Tests
• Share to Cell Adhesion Molecules